Today’s Top Three in Pharma 020309 posted on February 3, 2009Avastin + Tarceva = better results in lung cancer - Genentech said the trial was stopped early after an interim analysis found that combining Avastin, known generically as bevacizumab, and Tarceva, or …Continue Reading about Today’s Top Three in Pharma 020309 →